Adalimumab treatment for peristomal pyoderma gangrenosum associated with Crohn's disease

Inflamm Bowel Dis. 2009 Jun;15(6):803-6. doi: 10.1002/ibd.20748.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab
  • Adolescent
  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Colostomy / adverse effects*
  • Crohn Disease / complications*
  • Female
  • Humans
  • Pyoderma Gangrenosum / drug therapy*
  • Pyoderma Gangrenosum / etiology*
  • Pyoderma Gangrenosum / pathology

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Adalimumab